Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1987 1
1988 1
2005 1
2009 3
2010 5
2011 3
2012 2
2013 1
2014 1
2015 1
2016 5
2018 1
2019 2
2020 6
2021 6
2022 10
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers.
Lu Z, Mao W, Yang H, Santiago-O'Farrill JM, Rask PJ, Mondal J, Chen H, Ivan C, Liu X, Liu CG, Xi Y, Masuda K, Carrami EM, Chen M, Tang Y, Pang L, Lakomy DS, Calin GA, Liang H, Ahmed AA, Vankayalapati H, Bast RC Jr. Lu Z, et al. Among authors: lakomy ds. J Clin Invest. 2022 Jun 1;132(11):e146471. doi: 10.1172/JCI146471. J Clin Invest. 2022. PMID: 35642638 Free PMC article.
Killer dendritic cells and their potential for cancer immunotherapy.
Larmonier N, Fraszczak J, Lakomy D, Bonnotte B, Katsanis E. Larmonier N, et al. Among authors: lakomy d. Cancer Immunol Immunother. 2010 Jan;59(1):1-11. doi: 10.1007/s00262-009-0736-1. Epub 2009 Jul 18. Cancer Immunol Immunother. 2010. PMID: 19618185 Review.
T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patients.
Samson M, Nicolas B, Ciudad M, Greigert H, Guilhem A, Cladiere C, Straub C, Blot M, Piroth L, Rogier T, Devilliers H, Manckoundia P, Ghesquiere T, Francois S, Lakomy D, Audia S, Bonnotte B. Samson M, et al. Among authors: lakomy d. Eur J Intern Med. 2022 Aug;102:104-109. doi: 10.1016/j.ejim.2022.06.001. Epub 2022 Jun 3. Eur J Intern Med. 2022. PMID: 35690570 Free PMC article.
Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 Mutation.
Chapman BV, Liu D, Shen Y, Olamigoke OO, Lakomy DS, Barrera AMG, Stecklein SR, Sawakuchi GO, Bright SJ, Bedrosian I, Litton JK, Smith BD, Woodward WA, Perkins GH, Hoffman KE, Stauder MC, Strom EA, Arun BK, Shaitelman SF. Chapman BV, et al. Among authors: lakomy ds. Int J Radiat Oncol Biol Phys. 2022 Feb 1;112(2):426-436. doi: 10.1016/j.ijrobp.2021.09.033. Epub 2021 Oct 3. Int J Radiat Oncol Biol Phys. 2022. PMID: 34610390 Free PMC article.
Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing.
Chapman BV, Liu D, Shen Y, Olamigoke OO, Lakomy DS, Barrera AMG, Stecklein SR, Sawakuchi GO, Bright SJ, Bedrosian I, Litton JK, Smith BD, Woodward WA, Perkins GH, Hoffman KE, Stauder MC, Strom EA, Arun BK, Shaitelman SF. Chapman BV, et al. Among authors: lakomy ds. Int J Radiat Oncol Biol Phys. 2022 Feb 1;112(2):437-444. doi: 10.1016/j.ijrobp.2021.09.026. Epub 2021 Sep 25. Int J Radiat Oncol Biol Phys. 2022. PMID: 34582940 Free PMC article.
43 results